Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer
Clinical trial NCT00375752 · TERMINATED
Trial details
- NCT number
- NCT00375752
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2010-12-16
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.